Trinity Biotech (TRIB) Amortization of Goodwill (2021 - 2024)
Historic Amortization of Goodwill for Trinity Biotech (TRIB) over the last 4 years, with Q4 2024 value amounting to $962000.0.
- Trinity Biotech's Amortization of Goodwill rose 23172.41% to $962000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $4.3 million, marking a year-over-year increase of 204.83%. This contributed to the annual value of $1.4 million for FY2024, which is 8732.1% down from last year.
- Per Trinity Biotech's latest filing, its Amortization of Goodwill stood at $962000.0 for Q4 2024, which was up 23172.41% from $290000.0 recorded in Q4 2023.
- Trinity Biotech's Amortization of Goodwill's 5-year high stood at $3.0 million during Q4 2022, with a 5-year trough of $519.0 in Q2 2022.
- Moreover, its 4-year median value for Amortization of Goodwill was $583000.0 (2021), whereas its average is $861097.8.
- Within the past 5 years, the most significant YoY rise in Trinity Biotech's Amortization of Goodwill was 24611.87% (2022), while the steepest drop was 9144.69% (2022).
- Over the past 4 years, Trinity Biotech's Amortization of Goodwill (Quarter) stood at $876000.0 in 2021, then surged by 246.12% to $3.0 million in 2022, then tumbled by 90.44% to $290000.0 in 2023, then skyrocketed by 231.72% to $962000.0 in 2024.
- Its Amortization of Goodwill stands at $962000.0 for Q4 2024, versus $290000.0 for Q4 2023 and $3.0 million for Q4 2022.